首页> 外文期刊>The pharmaceutical journal >Patient consent in the UK
【24h】

Patient consent in the UK

机译:英国的患者同意书

获取原文
获取原文并翻译 | 示例
           

摘要

After a landmark ruling In the case of Montgomery v Lanarkshire Health Board at the UK Supreme Court in March 2015, patients must now be given information about any risks associated with their treatment for their consent to be legally valid. This means information that would enable the patient to make an informed decision should not be selective, even if a healthcare professional believes this is a reasonable judgement based on guidance from their professional body, or what a 'reasonable patient' needs to know.
机译:做出具有里程碑意义的裁决之后,在2015年3月英国最高法院的Montgomery诉Lanarkshire卫生局一案中,现在必须向患者提供有关其治疗相关风险的信息,以表示他们同意具有法律效力。这意味着使患者能够做出明智决定的信息不应是选择性的,即使医疗保健专业人员认为这是基于其专业机构的指导或“合理患者”需要知道的知识的合理判断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号